# Cell-Based Approaches For Modeling and Treating Ataxia-Telangiectasia

> **NCT02246491** · NA · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 6 (actual)

## Conditions studied

- Ataxia-Telangiectasia (A-T)

## Interventions

- **OTHER:** A-T iPS cell line
- **OTHER:** Carrier patients iPS cell line

## Key facts

- **NCT ID:** NCT02246491
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-02-03
- **Primary completion:** 2018-07-05
- **Final completion:** 2018-07-05
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Change in research objectives.
- **Last updated:** 2019-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02246491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02246491, "Cell-Based Approaches For Modeling and Treating Ataxia-Telangiectasia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02246491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*